The sympathomimetic agonist mirabegron did not lower


Journal

Haematologica
ISSN: 1592-8721
Titre abrégé: Haematologica
Pays: Italy
ID NLM: 0417435

Informations de publication

Date de publication:
04 2019
Historique:
received: 20 06 2018
accepted: 08 11 2018
pubmed: 10 11 2018
medline: 7 5 2020
entrez: 10 11 2018
Statut: ppublish

Résumé

The β-3 sympathomimetic agonist BRL37344 restored nestin-positive cells within the stem cell niche, and thereby normalized blood counts and improved myelofibrosis in a mouse model of

Identifiants

pubmed: 30409796
pii: haematol.2018.200014
doi: 10.3324/haematol.2018.200014
pmc: PMC6442970
doi:

Substances chimiques

Acetanilides 0
NES protein, human 0
Nestin 0
Reticulin 0
Sympathomimetics 0
Thiazoles 0
JAK2 protein, human EC 2.7.10.2
Janus Kinase 2 EC 2.7.10.2
mirabegron MVR3JL3B2V

Types de publication

Clinical Trial, Phase II Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

710-716

Subventions

Organisme : Medical Research Council
ID : MC_PC_12009
Pays : United Kingdom

Informations de copyright

Copyright© 2019 Ferrata Storti Foundation.

Références

Blood. 2013 Aug 22;122(8):1395-8
pubmed: 23838352
Histopathology. 2016 May;68(6):905-15
pubmed: 26402166
Nature. 2014 Aug 7;512(7512):78-81
pubmed: 25043017
Nature. 2010 Aug 12;466(7308):829-34
pubmed: 20703299
Cancer Cell. 2005 Apr;7(4):387-97
pubmed: 15837627
N Engl J Med. 2005 Jul 7;353(1):33-45
pubmed: 16000354
Eur Urol. 2013 Feb;63(2):283-95
pubmed: 23182126
Haematologica. 2005 Aug;90(8):1128-32
pubmed: 16079113
Blood. 2013 Jun 6;121(23):4778-81
pubmed: 23591792
Blood. 2016 May 19;127(20):2391-405
pubmed: 27069254
Blood. 2014 Apr 3;123(14):2220-8
pubmed: 24478400
N Engl J Med. 2005 Apr 28;352(17):1779-90
pubmed: 15858187
Lancet. 2005 Mar 19-25;365(9464):1054-61
pubmed: 15781101
J Urol. 2013 Apr;189(4):1388-95
pubmed: 23079373
Nature. 2005 Apr 28;434(7037):1144-8
pubmed: 15793561
Blood. 2006 Aug 15;108(4):1377-80
pubmed: 16675710
Blood. 2017 Mar 23;129(12):1607-1616
pubmed: 28159736
Eur J Haematol. 1990 Jan;44(1):33-8
pubmed: 2307218
Nature. 2008 Mar 27;452(7186):442-7
pubmed: 18256599
Blood. 2009 Jul 30;114(5):937-51
pubmed: 19357394

Auteurs

Beatrice Drexler (B)

Division of Hematology, University Hospital Basel and University of Basel, Switzerland.

Jakob R Passweg (JR)

Division of Hematology, University Hospital Basel and University of Basel, Switzerland jakob.passweg@usb.ch.

Alexandar Tzankov (A)

Institute of Pathology, University Hospital Basel and University of Basel, Switzerland.

Martin Bigler (M)

Swiss Group for Clinical Cancer Research, Bern, Switzerland.

Alexandre Pa Theocharides (AP)

Hematology and Oncology, University Hospital Zurich and University of Zurich, Switzerland.

Nathan Cantoni (N)

Oncology, Hematology & Transfusion Medicine, Kantonsspital Aarau AG, Switzerland.

Peter Keller (P)

University Clinic of Hematology and Central Hematology Laboratory, University Hospital Bern, Switzerland.

Georg Stussi (G)

Clinic of Hematology, Oncology Institute of Southern Switzerland, Bellinzona, Switzerland.

Axel Ruefer (A)

Departement Medizin, Luzerner Kantonsspital, Switzerland.

Rudolf Benz (R)

Kantonsspital Muensterlingen, Switzerland.

Geneviève Favre (G)

Cantonal Hospital Liestal, Switzerland.

Pontus Lundberg (P)

Division of Hematology, University Hospital Basel and University of Basel, Switzerland.

Ronny Nienhold (R)

Department of Biomedicine, Experimental Hematology, University Hospital Basel and University of Basel, Switzerland.

Andrea Fuhrer (A)

Swiss Group for Clinical Cancer Research, Bern, Switzerland.

Christine Biaggi (C)

Swiss Group for Clinical Cancer Research, Bern, Switzerland.

Markus G Manz (MG)

Hematology and Oncology, University Hospital Zurich and University of Zurich, Switzerland.

Mario Bargetzi (M)

Oncology, Hematology & Transfusion Medicine, Kantonsspital Aarau AG, Switzerland.

Simon Mendez-Ferrer (S)

Wellcome Trust-Medical Research Council Cambridge Stem Cell Institute, Department of Haematology, University of Cambridge, and National Health Service Blood and Transplant, Cambridge, UK.

Radek C Skoda (RC)

Department of Biomedicine, Experimental Hematology, University Hospital Basel and University of Basel, Switzerland radek.skoda@unibas.ch.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH